SharePost Content Read More Yahoo Finance #finance Post navigation Target Stock Is Near a 52-Week High and Wall Street Is Raising the Bar Corvus Pharmaceuticals (CRVS): This Clinical-Stage Drugmaker Just Got A Lot More Interesting